Literature DB >> 11576769

In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin.

A Boucaud1, L Machet, B Arbeille, M C Machet, M Sournac, A Mavon, F Patat, L Vaillant.   

Abstract

The effect of low-frequency sonophoresis on fentanyl and caffeine permeation through human and hairless rat skin was studied in vitro. Experiments were performed using 20 kHz ultrasound applied at either continuous or discontinuous mode and with an average intensity of 2.5 W/cm(2). The results showed that low-frequency ultrasound enhanced the transdermal transport of both fentanyl and caffeine across human and hairless rat skin. This was explained by both increasing flux during sonication and shortening the lag time. Discontinuous mode was found to be more effective in increasing transdermal penetration of fentanyl while transdermal transport of caffeine was enhanced by both continuous and pulsed mode. Histological and electron microscopy studies showed that human and hairless rat skin was unaffected by ultrasound exposure. Further studies will be necessary to determine the relative contribution of ultrasound parameters in low-frequency ultrasound-induced percutaneous enhancement of drug transport.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576769     DOI: 10.1016/s0378-5173(01)00820-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  Sonophoresis-mechanisms and application.

Authors:  Edina Vranić
Journal:  Bosn J Basic Med Sci       Date:  2004-05       Impact factor: 3.363

2.  Preparation and in vitro evaluation of a new fentanyl patch based on functional and non-functional pressure sensitive adhesives.

Authors:  Seyed Mojtaba Taghizadeh; Arezou Soroushnia; Fatemeh Mohamadnia
Journal:  AAPS PharmSciTech       Date:  2010-02-25       Impact factor: 3.246

3.  Fetal membrane transport enhancement using ultrasound for drug delivery and noninvasive detection.

Authors:  Lior Wolloch; Aharon Azagury; Riki Goldbart; Tamar Traitel; Gabriel Groisman; Mordechai Hallak; Joseph Kost
Journal:  Pharm Res       Date:  2014-07-31       Impact factor: 4.200

Review 4.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends.

Authors:  Baris E Polat; Douglas Hart; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2011-01-14       Impact factor: 9.776

5.  Low-Frequency Sonophoresis as an Active Approach to Potentiate the Transdermal Delivery of Agomelatine-Loaded Novasomes: Design, Optimization, and Pharmacokinetic Profiling in Rabbits.

Authors:  Mai Ahmed Tawfik; Magdy Ibrahim Mohamed; Mina Ibrahim Tadros; Sara Nageeb El-Helaly
Journal:  AAPS PharmSciTech       Date:  2021-10-27       Impact factor: 3.246

6.  The role of hair follicles in the percutaneous absorption of caffeine.

Authors:  Nina Otberg; Alexa Patzelt; Utkur Rasulev; Timo Hagemeister; Michael Linscheid; Ronald Sinkgraven; Wolfram Sterry; Jürgen Lademann
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

7.  Development of an optimised application protocol for sonophoretic transdermal delivery of a model hydrophilic drug.

Authors:  Omar Sarheed; Bazigha K Abdul Rasool
Journal:  Open Biomed Eng J       Date:  2011-03-15

Review 8.  Perspectives on transdermal ultrasound mediated drug delivery.

Authors:  Nadine Barrie Smith
Journal:  Int J Nanomedicine       Date:  2007

9.  Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment.

Authors:  Mai Ahmed Tawfik; Mina Ibrahim Tadros; Magdy Ibrahim Mohamed; Sara Nageeb El-Helaly
Journal:  Int J Nanomedicine       Date:  2020-11-12

10.  Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenac.

Authors:  Bin Huang; Wei-Jiang Dong; Gao-Yi Yang; Wei Wang; Cong-Hua Ji; Fei-Ni Zhou
Journal:  Drug Des Devel Ther       Date:  2015-07-23       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.